In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials (PDQ®)

Page Options

  • Print This Page
  • Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat

Clinical Trials (PDQ®)

A Study of the BRAF Inhibitor Dabrafenib in Combination With the MEK Inhibitor Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma After Surgical Resection.

Basic Trial Information
Trial Description
     Summary
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IIITreatmentActive18 and overPharmaceutical / Industry115532
NCT01682083

Trial Description

Summary

This is a two-arm, randomized, double-blind Phase III study of dabrafenib in combination with trametinib versus two placebos in the adjuvant treatment of melanoma after surgical resection. Patients with completely resected, histologically confirmed, BRAF V600E/K mutation-positive, high-risk [Stage IIIa (lymph node metastasis >1 mm), IIIb or IIIc] cutaneous melanoma will be screened for eligibility. Subjects will be randomized to receive either dabrafenib (150 milligram (mg) twice daily [BID]) and trametinib (2 mg once daily [QD]) combination therapy or two placebos for 12 months.

Eligibility Criteria

Inclusion Criteria:

  • Completely resected histologically confirmed high-risk [Stage IIIa (LN metastasis more than 1 mm), IIIb or IIIc cutaneous melanoma determined to be V600E/K mutation positive by a central laboratory. Patients presenting with initial resectable lymph node recurrence after a diagnosis of Stage I or II melanoma are eligible.
  • Surgically rendered free of disease no more than 12 weeks before randomization.
  • Recovered from definitive surgery (e.g. no uncontrolled wound infections or indwelling drains).
  • Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1.
  • Adequate hematologic, hepatic, renal and cardiac function.

Exclusion Criteria:

  • Known mucosal or ocular melanoma or the presence of unresectable in-transit metastases.
  • Evidence of distant metastatic disease.
  • Prior systemic anti-cancer treatment and radiotherapy for melanoma; prior surgery for melanoma is allowed.
  • History of another malignancy or concurrent malignancy including prior malignant melanoma. Exceptions to this include: Patients who have been disease-free for 5 years or patients with a history completely resected non-melanoma skin cancer or successfully treated in situ carcinoma are eligible, for example cervical cancer in situ, atypical melanocytic hyperplasia or melanoma in situ, multiple primary melanomas, or other malignancies for which the patient has been disease free for > 5 years.
  • History or current evidence of cardiovascular risk.
  • History or current evidence of retinal vein occlusion (RVO) or central serous retinopathy (CSR)

Trial Contact Information

Trial Lead Organizations/Sponsors

GlaxoSmithkline

GSK Clinical TrialsStudy Director

US GSK Clinical Trials Call CenterPh: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com

Trial Sites

U.S.A.
Alabama
  Birmingham
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Arizona
  Tucson
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
California
  San Francisco
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Colorado
  Aurora
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Connecticut
  Farmington
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Florida
  Fort Myers
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Lake Worth
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Orlando
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Tampa
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Georgia
  Atlanta
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Indiana
  Indianapolis
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Maryland
  Baltimore
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Lutherville Timonium
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Massachusetts
  Boston
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Michigan
  Ann Arbor
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
North Carolina
  Winston-Salem
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Ohio
  Cincinnati
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Columbus
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Oregon
  Portland
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Pennsylvania
  Pittsburgh
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Tennessee
  Nashville
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Texas
  Dallas
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Utah
  Murray
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Argentina
  Viedma
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Buenos Aires
  Caba
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Capital Federal
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Ciudad Autónoma de Buenos Aires
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Santa Fe
  Rosario
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Australia
  Nedlands
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
New South Wales
  Gateshead
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  North Sydney
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Tweed Heads
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Westmead
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Queensland
  Greenslopes
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Woolloongabba
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
South Australia
  Adelaide
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Victoria
  Box Hill
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Heidelberg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Melbourne
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Austria
  Graz
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Linz
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Salzburg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Wels
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Wien
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Belgium
  Brussels
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Leuven
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Liège
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Wilrijk
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Canada
  Quebec
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Alberta
  Edmonton
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Ontario
  Hamilton
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Oshawa
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Ottawa
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Toronto
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Quebec
  Montreal
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Czech Republic
  Brno
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Hradec Kralove
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Olomouc
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Praha 10
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Praha 2
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Zlin
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Denmark
  Århus C
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Herlev
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Odense
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
France
  Bordeaux
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Boulogne-Billancourt
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Brest cedex
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Dijon
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Grenoble
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Lille
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Marseille cedex 5
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Montpellier cedex 5
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Nice
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Paris
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Paris Cedex 10
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Pierre-Bénite cedex
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Reims Cedex
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Rennes Cedex
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Toulouse cedex 9
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Tours Cedex 9
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Villejuif cedex
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Germany
  Berlin
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Bochum
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Darmstadt
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Erfurt
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Essen
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Freiburg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Gera
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Hannover
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Heidelberg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Heilbronn
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Kiel
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Koeln
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Luebeck
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Magdeburg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Mainz
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Mannheim
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Marburg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Muenchen
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Muenster
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Nuernberg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Quedlinburg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Regensburg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Schwerin
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Tuebingen
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Ulm
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Wiesbaden
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Wuerzburg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Greece
  Athens
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Thessaloniki
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Israel
  Jerusalem
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Ramat Gan
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Italy
  Bergamo
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Candiolo
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Genova
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Milano
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Padova
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Pisa
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Roma
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Japan
  Shizuoka
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Tokyo
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Netherlands
  Amsterdam
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Groningen
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Leeuwarden
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Maastricht
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Nijmegen
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Rotterdam
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
New Zealand
  Auckland
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Norway
  Ålesund
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Oslo
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Poland
  Gdansk
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Konin
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Poznan
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Warszawa
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Russia
  Chelyabinsk
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Moscow
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Ryazan
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  St. Petersburg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Volzhsky
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Spain
  Badalona
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Barcelona
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Cartagena (Murcia)
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Las Palmas De Gran Canaria
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Madrid
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Málaga
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Palma de Mallorca
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Pamplona
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  San Sebastián
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Santander
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Sevilla
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Valencia
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Sweden
  Göteborg
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Lund
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Stockholm
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Uppsala
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Switzerland
  Basel
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Chur
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Zürich
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
Taiwan
  Taichung
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Taipei
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Taoyuan
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
United Kingdom
  Exeter
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Glasgow
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Guildford
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Leeds
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  London
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Manchester
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Newcastle upon Tyne
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Northwood
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Norwich
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Preston
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Southampton
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com
  Sutton
 GSK Investigational Site
 US GSK Clinical Trials Call Center Ph: 877-379-3718
  Email: GSKClinicalSupportHD@gsk.com
 EU GSK Clinical Trials Call Center Ph: +44 (0) 20 8990 4466
  Email: GSKClinicalSupportHD@gsk.com

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT01682083
ClinicalTrials.gov processed this data on September 25, 2014

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.

Back to TopBack to Top